share_log

Avenue Therapeutics Q4 EPS $(0.98) Misses $(0.10) Estimate

Moomoo 24/7 ·  Mar 18 16:15

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.10) by 880 percent. This is a 20.33 percent increase over losses of $(1.23) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment